Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02655055 · ClinicalTrials.gov registry record · NA
Bone Density in Voluntary Apheresis Blood Donors
A NA study, sponsored by Versiti Blood Health.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02655055 is a NA study that has completed, run by Versiti Blood Health. The registered enrollment target is 58 participants.
The verdict
NCT02655055, a NA study, has completed, sponsored by Versiti Blood Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
A longitudinal, randomized, controlled, single-center Phase IV clinical trial will be performed to assess changes in bone mineral density (BMD) among voluntary apheresis blood donors. The primary outcome measure will be clinically significant decline in BMD at the lumbar spine assessed by dual-energy x-ray absorptiometry (DXA).
Interventions
- PROCEDURE high frequency voluntary apheresis blood donation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02655055
The ClinicalTrials.gov registry entry for NCT02655055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Versiti Blood Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which high frequency voluntary apheresis blood donation is the first listed.
NCT02655055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02655055 about?
NCT02655055 is a clinical study titled "Bone Density in Voluntary Apheresis Blood Donors". A longitudinal, randomized, controlled, single-center Phase IV clinical trial will be performed to assess changes in bone mineral density (BMD) among voluntary apheresis blood donors. The primary outcome measure will be clinically significant decline in BMD at the lumbar spine assessed by dual-energ...
What is the current status of trial NCT02655055?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2016-05. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02655055?
The interventions under investigation include: high frequency voluntary apheresis blood donation (PROCEDURE).
Who is sponsoring clinical trial NCT02655055?
This trial is sponsored by Versiti Blood Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.